Evidence map›Paper›PMID 34572143›Full record

ArticleCells2021

Metabolomic Fingerprint of Mecp2-Deficient Mouse Cortex: Evidence for a Pronounced Multi-Facetted Metabolic Component in Rett Syndrome.

Gocha Golubiani, Vincenzo Lagani, Revaz Solomonia, Michael Müller

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Gocha GolubianiInstitut für Neuro- und Sinnesphysiologie, Zentrum Physiologie und Pathophysiologie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen, D-37130 Göttingen, Germany.ORCID 0000-0002-6274-9047
Vincenzo LaganiInstitute of Chemical Biology, Ilia State University, 0162 Tbilisi, Georgia.ORCID 0000-0002-6552-6076
Revaz SolomoniaInstitute of Chemical Biology, Ilia State University, 0162 Tbilisi, Georgia.
Michael MüllerInstitut für Neuro- und Sinnesphysiologie, Zentrum Physiologie und Pathophysiologie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen, D-37130 Göttingen, Germany.
Ilia State University · GEUniversitätsmedizin Göttingen · DE

Funding

Deutsche Forschungsgemeinschaft 456368804Volkswagen Stiftung & Shota Rustaveli Science Foundation of Georgia Carl Friedrich Lehman-Haupt International Doctoral Program
6 · The paper itself

Abstract

Using unsupervised metabolomics, we defined the complex metabolic conditions in the cortex of a mouse model of Rett syndrome (RTT). RTT, which represents a cause of mental and cognitive disabilities in females, results in profound cognitive impairment with autistic features, motor disabilities, seizures, gastrointestinal problems, and cardiorespiratory irregularities. Typical RTT originates from mutations in the X-chromosomal methyl-CpG-binding-protein-2 (

Indexed as

AnimalsBrainCerebral CortexDisease Models, AnimalDisease ProgressionMaleMetabolomicsMethyl-CpG-Binding Protein 2MiceMitochondriaMutationPhenotypeRett SyndromeMecp2 protein, mouseMethyl-CpG-Binding Protein 2amino acidscarbohydratesMecp2metabolismmitochondriapathogenic mechanismRett syndrome

Identifiers

PMID34572143
PMCPMC8472238
OpenAlexW3199779582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.